Table 2.
Clinical characteristics of the patients
| Associated symptoms | n (%) | |
| Hearing loss | 61 (88.4) | |
| Tinnitus | 55(79.7) | |
| Vertigo | 23 (33.3) | |
| Otalgia | 17 (24.6) | |
| Fullness in the ear | 18 (26.1) | |
|
Duration of symptoms before presentation (years) | ||
| Duration (years) | ||
| 0.1–1.0 | 30 (43.5) | |
| 1.1–2.0 | 11 (15.9) | |
| 2.1–3.0 | 10 (14.5) | |
| 3.1–4.0 | 4 (5.8) | |
| 4.1– 5.0 | 1 (1.4) | |
| > 5.1 | 13 (18.8) | |
| Mean=2.6 +/−1.9years; | Median =2.0 years | |
| Possible risk factors | ||
| Positive Family history | 8 (11.6) | |
| Exposure to noise | 15 (21.7) | |
| Previous use of ototoxic drug | 17 (24.6) | |
| Alcohol consumption | 10 (14.5) | |
| Smoking | 5 (7.3) | |
| Hypertension | 24 (34.8) | |
| Diabetes | 6 (8.7) | |
| Osteoarthritis | 9 (13.0) | |
| Peptic ulcer disease | 1 (1.5) | |
| Glaucoma | 1 (1.5) | |
| Asthma | 1 ( 1.5) | |